Comment | Published:

Transition to chronic pain: opportunities for novel therapeutics


Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information


Federal Pain Research Strategy:

NIH policy:


  1. 1.

    Ji, R. R., Chamessian, A. & Zhang, Y. Q. Science 354, 572–577 (2016).

  2. 2.

    Apkarian, A. V., Baliki, M. N. & Farmer, M. A. Curr. Opin. Neurol. 26, 360–367 (2013).

  3. 3.

    Denk, F., McMahon, S. B. & Tracey, I. Nat. Neurosci. 17, 192–200 (2014).

  4. 4.

    Skolnick, P. & Volkow, N. D. Neuron 92, 294–297 (2016).

  5. 5.

    Braz, J. M. et al. Neuron 74, 663–675 (2012).

  6. 6.

    Gewandter, J. S. et al. Pain 156, 1184–1197 (2015).

Download references


We thank the Interagency Pain Research Coordinating Committee of the US National Institutes of Health, who facilitated and provided financial support for meetings of the working group.

Author information

Competing interests

The authors declare no competing interests.

Correspondence to Theodore J. Price.

Supplementary information

  1. Supplementary Figures

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Further reading